Home › Chronic Lymphocytic Leukemia › Texas › Houston

Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Houston, TX

Isang pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Nagre-recruitPhase 1/2

Research Site, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06542250

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Nagre-recruitPhase 1/2

Md Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05006716

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Nagre-recruitPhase 3

Md Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06973187

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Nagre-recruitPhase 3

The University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07648264

Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT04169737

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Nagre-recruitPhase 1/2

Research Site, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06564038

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Nagre-recruitPhase 1/2

MD Anderson, Houston

Edad 12 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT04588922

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

UT MD Anderson Cancer Center, Houston

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05334069

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

University of Texas MD Anderson Cancer Center, Houston

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).

Nagre-recruitPhase 2

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT06967610

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05131022

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Nagre-recruitPhase 1

MD Anderson Cancer Center, Houston

Edad 13 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT04771572

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT04830137

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Nagre-recruitPhase 4

University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Nagre-recruitPhase 4

University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876662

Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

Nagre-recruitPhase 1

Houston Methodist Hospital, Houston
Texas Children's Hospital, Houston

Hanggang edad 75 · Lahat ng kasarian · Na-update Ene 5, 2026 · NCT01853631

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

Oncology Consultants, Houston
University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 10, 2025 · NCT05602363

Pag-aaral para sa Chronic Lymphocytic Leukemia sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.